Page 18 - 《中国药房》2024年10期
P. 18

医疗机构中药制剂立项评价体系的构建及应用
                                                                                  Δ


                                                     1
                                                                     1
                                                             1
                                                                             5
                                   3, 4
                                                                                      1 #
                 1*
          鞠晓宇 ,赵 靓 ,赵 越 ,唐 贺 ,张静宜 ,李俊雪 ,薛玉润 ,关胜江 ,程 杰 [1.河北省中医院药学部,
                           2
                                            1
          石家庄 050011;2.河北省药品职业化检查员总队(南片区),石家庄 050051;3.河北省人民医院药学部,石家庄
          050054;4.河北省临床药学重点实验室,石家庄 050054;5.河北省中医院院长办公室,石家庄 050011]
          中图分类号  R943;R288      文献标志码  A      文章编号  1001-0408(2024)10-1168-06
          DOI  10.6039/j.issn.1001-0408.2024.10.03
          摘   要  目的  以新药转化为导向,构建医疗机构中药制剂备案立项评价体系,以提高医疗机构中药制剂的申报成功率,为后期新
          药转化奠定基础。方法  我院研发小组运用文献研究法,采用头脑风暴法列举并整理医疗机构中药制剂立项评价的相关要素,确
          定初拟指标体系;采用德尔菲法进行专家函询,确定评价指标,根据各指标的重要性评分占比计算权重,赋予具体分值,并采用该
          指标体系对2023年4-7月我院各科室申请备案的31个中药制剂进行评价。结果  向17位专家进行了两轮函询,最终确定的医疗
          机构中药制剂备案立项评价体系包括理论依据、临床研究基础、药学基础、处方、临床价值5项一级指标,以及处方来源、中医理
          论、临床定位等17项二级指标,其中人用经验为一票否决项。基于上述指标体系,我院进一步完善了医疗机构中药制剂备案立项
          流程,并从2023年4-7月各科室申请备案的31个中药制剂中,遴选出8个评分≥65分的中药制剂拟进行开发。结论  本评价体
          系客观、全面,可操作性强,适用于医疗机构中药制剂研发前的遴选。
          关键词  医疗机构中药制剂;立项评价;人用经验;新药转化;德尔菲法


          Construction  and  application  of  the  project  approval  evaluation  system  for  traditional  Chinese  medicine
          preparation in medical institutions
                                                                                        1
                                                            1
                                                                            1
                                               3, 4
          JU Xiaoyu ,ZHAO Liang ,ZHAO Yue ,TANG He ,ZHANG Jingyi ,LI Junxue ,XUE Yurun ,GUAN
                                                                                                     1
                                  2
                    1
          Shengjiang ,CHENG Jie [1.  Dept.  of  Pharmacy,  Hebei  Provincial  Hospital  of  Chinese  Medicine,  Shijiazhuang
                    5
                                1
          050011,  China;2.  General  Team  of  Drug  Professionalization  Inspectors  of  Hebei  Province (Southern  District),
          Shijiazhuang  050051,  China;3.  Dept.  of  Pharmacy,  Hebei  General  Hospital,  Shijiazhuang  050054,  China;
          4.  Hebei  Key  Laboratory  of  Clinical  Pharmacy,  Shijiazhuang  050054,  China;5.  Dean  Office,  Hebei  Provincial
          Hospital of Chinese Medicine, Shijiazhuang 050011, China]
          ABSTRACT    OBJECTIVE  To  establish  the  project  approval  evaluation  system  for  traditional  Chinese  medicine (TCM)
          preparations  in  medical  institutions  guided  by  new  drug  conversion,  to  improve  the  success  rate  of  approval  for TCM  preparations
          in  medical  institutions  and  lay  the  foundation  for  the  later  drug  conversion.  METHODS  Research  and  development  team  used  the
          literature  research  method  and  brainstorming  method  to  list  and  organize  relevant  elements  of  project  evaluation  and  determine  the
          initial  indicator  system.  Experts  were  consulted  using  the  Delphi  method  to  confirm  the  evaluation  index.  The  weights  were
          calculated  based  on  the  proportion  of  importance  scores  for  each  indicator  and  assigned  specific  scores  to  each  item. The  indicator
          system was used to evaluate 31 TCM preparations applied for filing by various departments of our hospital from April to July 2023.

          RESULTS  After  two  rounds  of  17  experts’  consultation,  the  final  TCM  preparation  system  included  five  primary  indicators,  i.e.
          theoretical basis, clinical research foundation, pharmaceutical foundation, prescription, and clinical value, as well as 17 secondary
          indicators including prescription source, traditional Chinese medicine theory, clinical positioning and so on. Human experience was
          considered as the item which would be rejected as one vote. Based on the above indicator system, our hospital further improved the
                                                              filing  and  project  approval  process  for  TCM  preparations  in
              Δ 基金项目 河北省医学科学研究课题(No.20240488);河北省中            medical  institutions.  Among  the  31  TCM  preparations  applied
          医药管理局科研计划项目(No. 2022027)                            for  filing  by  various  departments  from  April  to  July  2023,  8
             *第一作者 主管药师,硕士。研究方向:中药临床药学。E-mail:
                                                              TCM  preparations  with  a  score  ≥65  were  selected  for
          1052675232@qq.com
                                                              development.  CONCLUSIONS  The  evaluation  system  is
              # 通信作者 主任药师,硕士。研究方向:医院药事管理。电话:
          0311-69095306。E-mail:323240022@qq.com               objective,  comprehensive,  and  highly  operable.  It  is  suitable


          · 1168 ·    China Pharmacy  2024 Vol. 35  No. 10                            中国药房  2024年第35卷第10期
   13   14   15   16   17   18   19   20   21   22   23